Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Published Phase 3 weight-loss results for retatrutide exceed those reported for tirzepatide (22.5% in SURMOUNT-1) and semaglutide (14.9% in STEP-1) at comparable timepoints [1][2][9]
Some researchers are exploring maintenance dosing strategies, where individuals reach their target weight at full dose and then step down to a lower maintenance dose to sustain results with fewer side effects and lower cost
To determine the efficacy and safety of tirzepatide, a phase 2 clinical trial was conducted with 190 patients, who were randomly assigned to receive weekly doses of 5, 10, or 15 mg or placebo, for 52 weeks
Retrieved from American Heart Association
Each method targets a different depth of pigmentation: lasers break up deeper melanin, peels remove dull surface cells, and glutathione improves brightness from within
Take that dose away, and the mimicry stops
US$ 22.18
US$ 25.57
US$ 20.56
US$ 26.64
US$ 23.27
US$ 20.17
